ARCHIVES

FDA Orders More Changes In ESA Label,

This article is from The Cancer Letter archive.

Vol. 34 No. 31 | August 8, 2008

Download PDF Visit The Full Archive

Related Articles

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

In Brief: Visco Elected Chairman of DOD Panel; Breast Cancer Stamp Raises $4.9 Million

February 19, 1999

New Announcement For CREG On Radio-Chemotherapy Combines Study New Available

July 28, 1978

Caution Advised for Hormone Replacement Therapy

March 21, 1986

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

Sole Source Negotiations

March 7, 1975